688276 百克生物
按盤價 
19.090 -0.280 (-1.446%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -3.871 | 5.635 | 13.219 | 5.204 | 9.372 |
| 總資產報酬率 ROA (%) | -3.039 | 4.528 | 10.740 | 4.293 | 7.334 |
| 投入資產回報率 ROIC (%) | -3.689 | 5.548 | 13.164 | 5.189 | 9.342 | 邊際利潤分析 |
| 銷售毛利率 (%) | 75.404 | 85.422 | 90.233 | 87.193 | 88.291 |
| 營業利潤率 (%) | -47.787 | 20.982 | 30.651 | 17.445 | 21.788 |
| 息稅前利潤/營業總收入 (%) | -42.864 | 20.503 | 30.225 | 16.574 | 20.833 |
| 淨利潤/營業總收入 (%) | -33.355 | 18.883 | 27.457 | 16.943 | 20.262 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 75.539 | 117.164 | 113.717 | 128.993 | 131.366 |
| 價值變動淨收益/利潤總額(%) | 12.012 | -0.172 | 0.122 | 0.156 | -0.391 |
| 營業外收支淨額/利潤總額(%) | -10.825 | -0.827 | 0.792 | 5.452 | -0.128 | 償債能力分析 |
| 流動比率 (X) | 1.395 | 2.142 | 2.212 | 2.872 | 2.925 |
| 速動比率 (X) | 1.197 | 1.956 | 2.016 | 2.603 | 2.603 |
| 資產負債率 (%) | 24.041 | 18.965 | 20.330 | 16.902 | 18.135 |
| 帶息債務/全部投入資本 (%) | 6.783 | 2.223 | 0.270 | 0.076 | 0.062 |
| 股東權益/帶息債務 (%) | 1,371.057 | 4,388.118 | 36,887.943 | 130,705.826 | 161,096.588 |
| 股東權益/負債合計 (%) | 315.951 | 427.278 | 391.895 | 491.638 | 451.433 |
| 利息保障倍數 (X) | -168.222 | -66.861 | -45.043 | -8.828 | -22.468 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 736.608 | 434.859 | 249.781 | 291.029 | 224.188 |
| 存貨周轉天數 (天) | 466.417 | 371.489 | 395.045 | 568.563 | 495.593 |
| 備註： | 即時報價更新時間為 16/12/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
